Mednet Logo
CommunityRadiation Oncology

Are there situations in which you would definitely recommend radiation in an elderly patient with ER+, early stage breast cancer?

Would multifocality, multicentricity, LVSI, N1mi, etc affect your decision making?
6 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Brown University
Answered on

I always have a little trepidation in answering questions whereby I would “definitely” recommend any therapeutic path as clinical decision making needs to be a bit more nuanced. Every situation requires a careful weighing of multiple inputs including clinical trial data and patient-specific fact...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Duke University Medical Center
Answered on

Dr Wazer has written a thoughtful scholarly answer to this question with which I agree, but I would emphasize his concluding sentences. Too little attention has been paid to the issue of RT alone vs hormonal rx alone and the relative toxicities of each. Particularly with the use of AI's, compliance ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Washington University School of Medicine
Answered on

I wholeheartedly agree with @Dr. First Last and @Dr. First Last. Their answers do take us a few steps away from the original question to the larger issue of what if any adjuvant therapy is needed for women with small breast cancers.

It is disappointing that the option of adjuvant radiation alone was ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Allegheny Health Network, Pittsburgh
Answered on

One additional factor is patient willingness to proceed with endocrine therapy and be compliant on treatment. Otherwise, I use high grade, nodal positivity, multicentricity

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

At I present would offer RT for high grade (based on prime2) or node positive disease (not included in prime or CALGB)

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Cancer Care Centers of Brevard
Answered on

15-20 year+ life expectancy.

The Calgb trial did in fact show a difference in IBTR rates, it's just that that difference was not felt to be clinically significant at 10 years of follow up. That rate of recurrence is a function of time and will increase with further follow up.

If a 70-75 year yo fem...

Join for free or sign in to see the full answer